West Syndrome Market Analysis Shows Promising Prospects For Emerging Drugs Over The Forecast Period (2021-30)


“West Syndrome Market”

The current therapeutic landscape for West syndrome in the United States is shaped by current treatment practices and the planned introduction of new therapies.

DelveInsight West Syndrome Market Report offers in-depth information on current treatment practices, emerging drugs, West syndrome market share of individual therapies, current and forecast West syndrome market size from 2018 to 2030 segmented into 7 MM (United States) , EU5 (UK, Spain, Germany, Italy and France) and Japan).

Key Points From The West Syndrome Market Report

  • According to estimates by DelveInsight, the total number of prevalent cases diagnosed for West syndrome was 8,601 in the 7MM in 2020, with the United States representing the maximum number of cases
  • Delvelnsight also looked at gender-specific data for West syndrome, which clearly shows that it is more common in men than in women.
  • Among the EU5 countries, France had the highest diagnosed cases in 2020.
  • Major companies in the West Syndrome market include Amzell, BioPharm Solutions, Cerecin, and others.
  • Key West Syndrome pipeline therapies include AMZ002, JBPOS0101, Tricapriline, and others.
  • The FDA has also granted JBPOS0101 (Biopharmaceutical solutions) Orphan drug status for West syndrome.
  • The US FDA has granted AMZ002 (Amzell) Rare pediatric diseases and orphan drug designations.

Request for sample West Syndrome market report to learn more about the emerging pharmaceutical landscape @ West Syndrome Market Landscape

Overview of West Syndrome

West syndrome is an age-related specific epileptic encephalopathy caused by various factors. It is distinguished by a distinct type of seizure known as epileptic (infantile) spasms and gross EEG abnormalities indicating hypsarrhythmia.

Segmentation of the epidemiology of West syndrome

The West Syndrome report offers an epidemiological analysis for the 2018-30 study period in the 7MM segmented into:

  • Total prevalent population of West syndrome
  • Total prevalent population diagnosed with West syndrome
  • Prevalent population diagnosed by sex of West syndrome

West Syndrome Treatment Landscape

The main treatment options for West syndrome include:

  • Corticosteroids and other off-label therapies
  • Acthar gel injection (corticotropin; ACTH)
  • Ketogenic diet
  • Sabril (vigabatrin)

West Syndrome Market Outlook

The current therapeutic landscape for West syndrome in the United States is shaped by current treatment practices and the planned introduction of new therapies. According to analysts at DelveInsight, the West Syndrome market is expected to experience positive growth during the forecast period, mainly due to the increase in the diagnosed prevalence and the launch of upcoming therapies.

Learn more about the future drug market share @ West Syndrome Market Analysis

West Syndrome Pipeline Therapies and Key Companies

  • AMZ002: Amzell
  • JBPOS0101: Biopharmaceutical solutions
  • Tricapriline: Cerecin



Key ideas


West Syndrome Market Overview at a Glance


Executive summary of West syndrome


West Syndrome: Background and Overview of the Disease


Diagnostic algorithm for West syndrome


Clinical Algorithm for Epileptic Spasms (Infantile Spasms) by Texas Children’s Hospital


Epidemiology and patient population


Country Wise-Epidemiology of West Syndrome




West Syndrome Treatment Algorithm


Guidelines for the management and treatment of childhood epileptic seizures


Recognized establishments


Unmet needs


Marketed profiles


Emerging drugs


West Syndrome: 7 Major Market Analyzes


US market outlook


EU-5 Countries: Market Outlook


Japanese market outlook


Case reports


Market factors


Market barriers


SWOT Analysis of West Syndrome




Features of DelveInsight




About DelveInsight

Contact our sales manager for Healthcare Due Diligence Services

Related reports

West Nile encephalitis market

DelveInsight “West Nile Encephalitis – Market Overview, Epidemiology, and Market Forecast-2030″ The report offers an in-depth understanding of West Nile encephalitis, historical and predicted epidemiology, as well as West Nile encephalitis in 7MM market trends.

About DelveInsight

DelveInsight is a leading business consulting and market research firm focused exclusively on the life sciences. It supports pharmaceutical companies by providing them with complete end-to-end solutions to improve their performance.

Media contact
Company Name: DelveInsight Business Research LLP
Contact: Sandeep Joshi
E-mail: Send an email
Call: 9193216187
Address:304, boul. S. Jones # 2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/


Comments are closed.